Login / Signup

An international comparison of anti-SARS-COV-2 assays used for seroprevalence surveys from blood component providers.

Antoine LewinSteven J DrewsRyanne Lieshout-KrikkeChristian ErikstrupSahar SaeedHelen M FaddySamra UzicaninBrian S CusterSheila F O'Briennull null
Published in: Vox sanguinis (2021)
Our results highlight the diversity of assays being used. Analyses comparing blood donor seroprevalence across countries should consider assay characteristics with optimization of signal/cut-off ratios and consistent methodology to adjust for waning antibody.
Keyphrases
  • sars cov
  • high throughput
  • respiratory syndrome coronavirus
  • single cell
  • coronavirus disease
  • clinical evaluation